NEK9 and cancer: Indeed, a study [242] has shown that Nek9 is responsible for gemcitabine sensitivity in cancer cells, where depletion of this kinase sensitizes cells to replication stress and reduces recovery, clearly implicating Nek9 in cancer cell survival signals.